{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:01:09Z","timestamp":1794528069867,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Community's Seventh Framework Programme","award":["611736"],"award-info":[{"award-number":["611736"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13011-018-0149-2","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:16:34Z","timestamp":1522800994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A comparative analysis of pharmacists\u2019 perspectives on codeine use and misuse \u2013 a three country survey"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5400-0565","authenticated-orcid":false,"given":"Tara","family":"Carney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D. H.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padraig","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Claire","family":"Van Hout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"issue":"5","key":"149_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000337028","volume":"18","author":"A Casati","year":"2012","unstructured":"Casati A, Sedefov R, Pfeiffer-Gerschel T. Misuse of medicines in the European Union: a systematic review of the literature. Eur Addict Res. 2012;18(5):228\u201345.","journal-title":"Eur Addict Res"},{"key":"149_CR2","volume-title":"The non medicinal use of prescription drugs","author":"UNODC","year":"2011","unstructured":"UNODC. The non medicinal use of prescription drugs. Vienna: United Nations; 2011."},{"key":"149_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drugpo.2015.09.007","volume":"27","author":"M Van Hout","year":"2016","unstructured":"Van Hout M, Norman I. Over the counter codeine misuse: recommendations for detection and reduction of risk in community pharmacies. Int J Drug Policy. 2016;27:17\u201322.","journal-title":"Int J Drug Policy."},{"key":"149_CR4","volume-title":"Narcotic drugs - yellow list","author":"INCB","year":"2011","unstructured":"INCB. Narcotic drugs - yellow list. International Narcotics Control Board: Austria; 2011."},{"key":"149_CR5","first-page":"CD010107","volume":"2","author":"S Derry","year":"2015","unstructured":"Derry S, Karlin SM, Moore R. Single dose oral ibuprofen plus codeine for acute postoperative pain in adults. Cochrane Database Sys Rev. 2015;2:CD010107.","journal-title":"Cochrane Database Sys Rev"},{"key":"149_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/7854_2015_422","volume":"34","author":"S Nielsen","year":"2016","unstructured":"Nielsen S, Van Hout MC. Over-the-counter codeine \u2013from therapeutic use to dependence, and the grey areas in between. Curr Top Behav Neurosci. 2016;34:59\u201375.","journal-title":"Curr Top Behav Neurosci"},{"issue":"4","key":"149_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1108\/DAT-03-2014-0014","volume":"14","author":"MC Van Hout","year":"2014","unstructured":"Van Hout MC. Doctor shopping and pharmacy hopping: practice innovations relating to codeine. Drug Alcohol Today. 2014;14(4):219\u201334.","journal-title":"Drug Alcohol Today"},{"key":"149_CR8","volume-title":"Over the counter codeine dependence","author":"S Nielsen","year":"2010","unstructured":"Nielsen S, Cameron J, Pahoki S. Over the counter codeine dependence. Turning Point Alcohol and Drug Centre: Victoria, Australia; 2010."},{"key":"149_CR9","volume-title":"\u2018Respectable addiction\u2019 - a qualitative study of over the counter medicine abuse in the UK","author":"R Cooper","year":"2011","unstructured":"Cooper R. \u2018Respectable addiction\u2019 - a qualitative study of over the counter medicine abuse in the UK. London: Pharmacy Practice Research Trust; 2011."},{"key":"149_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/14659891.2011.615002","volume":"18","author":"RJ Cooper","year":"2013","unstructured":"Cooper RJ. Over-the-counter medicine abuse: a review of the literature. J Subs Use. 2013;18:82\u2013107.","journal-title":"J Subs Use"},{"issue":"1","key":"149_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/tc.12.1.21","volume":"12","author":"JR Hughes","year":"2003","unstructured":"Hughes JR, Shiffman S, Callas P, Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control. 2003;12(1):21\u20137.","journal-title":"Tob Control"},{"issue":"2","key":"149_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/fampra\/cmh723","volume":"22","author":"M Wazaify","year":"2005","unstructured":"Wazaify M, Shields E, Hughes CM, McElnay JC. Societal perspectives on over-the-counter (OTC) medicines. Fam Pract. 2005;22(2):170\u20136.","journal-title":"Fam Pract."},{"key":"149_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1023\/B:PHAR.0000042891.66983.60","volume":"26","author":"GF Fleming","year":"2004","unstructured":"Fleming GF, McElnay JC, Hughes CM. Development of a community pharmacy-based model to identify and treat over the counter drug abuse\/misuse: a pilot study. Pharm World Sci. 2004;26:282\u20138.","journal-title":"Pharm World Sci"},{"key":"149_CR14","doi-asserted-by":"crossref","unstructured":"Carney T, Wells J, Bergin M, Dada S, Foley M, McGuiness P, et al. A comparative community pharmacists\u2019 views on the nature and management of over-the-counter (OTC) and prescription codeine misuse in three regulatory regimes: Ireland, South Africa and the United Kingdom. Int J Ment Health Addict. 2016;14:351\u20139.","DOI":"10.1007\/s11469-016-9640-z"},{"key":"149_CR15","doi-asserted-by":"publisher","first-page":"e002913","DOI":"10.1136\/bmjopen-2013-002913","volume":"3","author":"R Cooper","year":"2013","unstructured":"Cooper R. \u2018I can\u2019t be an addict. I am.\u2019 Over-the-counter medicine abuse: a qualitative study. BMJ Open. 2013;3:e002913.","journal-title":"BMJ Open"},{"key":"149_CR16","volume-title":"Over-the-counter ibuprofen\/codeine analgesics: misuse and harm","author":"M Dobbin","year":"2008","unstructured":"Dobbin M, Tobin CL. Over-the-counter ibuprofen\/codeine analgesics: misuse and harm. Drugs Policy and Services Branch Department of Human Services: Melbourne; 2008."},{"key":"149_CR17","first-page":"179","volume":"268","author":"R Pates","year":"2002","unstructured":"Pates R, McBride A, Li S, Ramadan R. Misuse of over-the-counter medicines: a survey of community pharmacies in a South Wales health authority. Pharm J. 2002;268:179\u201382.","journal-title":"Pharm J"},{"issue":"5","key":"149_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5055\/jom.2011.0077","volume":"7","author":"S Nielsen","year":"2011","unstructured":"Nielsen S, Cameron J, Lee N. Characteristics of a non-treatment seeking sample of over-the-counter codeine users: implications for intervention and prevention. J Opioid Manag. 2011;7(5):363\u201370.","journal-title":"J Opioid Manag"},{"key":"149_CR19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.puhe.2015.06.014","volume":"129","author":"M Foley","year":"2015","unstructured":"Foley M, Harris R, Rich E, Rapca A, Bergin M, Norman I, et al. The availability of over-the-counter codeine medicines across the European Union. Public Health. 2015;129:1465\u201370.","journal-title":"Public Health"},{"issue":"1346","key":"149_CR20","first-page":"29","volume":"124","author":"BR McAvoy","year":"2011","unstructured":"McAvoy BR, Dobbin MD, Tobin CL. Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand. N Z Med J. 2011;124(1346):29\u201333.","journal-title":"N Z Med J"},{"issue":"4","key":"149_CR21","first-page":"669","volume":"10","author":"AM Hamer","year":"2014","unstructured":"Hamer AM, Spark MJ, Wood PJ, Roberts E. The upscheduling of combination analgesics containing codeine: the impact on the practice of pharmacists. RSAP. 2014;10(4):669\u201378.","journal-title":"RSAP"},{"issue":"9","key":"149_CR22","doi-asserted-by":"publisher","first-page":"776","DOI":"10.7196\/SAMJnew.8172","volume":"105","author":"S Dada","year":"2015","unstructured":"Dada S, Harker Burnhams N, Van Hout MC, Parry CDH. Codeine misuse and dependence in South Africa-learning from substance use treatment admissions. SAMJ. 2015;105(9):776\u20139.","journal-title":"SAMJ"},{"issue":"10","key":"149_CR23","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1111\/add.13047","volume":"110","author":"C Parry","year":"2015","unstructured":"Parry C, Deluca P, Cooper R, Van Hout MC. Do we have sufficient information to optimally inform regulatory or other policy decisions about medications containing codeine? Addiction. 2015;110(10):1690\u20132.","journal-title":"Addiction"},{"issue":"3","key":"149_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/hsc.12012","volume":"21","author":"R Cooper","year":"2013","unstructured":"Cooper R. Surveillance and uncertainty: community pharmacy responses to over the counter medicine abuse. Health Soc Care Community. 2013;21(3):254\u201362.","journal-title":"Health Soc Care Community"},{"issue":"3","key":"149_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/146642400112100316","volume":"121","author":"L MacFayden","year":"2001","unstructured":"MacFayden L, Eadie D, McGowan T. Community pharmacists\u2019 experience of over-the-counter medicine misuse in Scotland. J R Soc Promo Health. 2001;121(3):185\u201392.","journal-title":"J R Soc Promo Health"},{"key":"149_CR26","first-page":"66","volume":"269","author":"C Matheson","year":"2002","unstructured":"Matheson C, Bond C, Pitcairn J. Misuse of over-the-counter medicines from community pharmacies: a population survey of Scottish pharmacists. Pharm J. 2002;269:66\u20138.","journal-title":"Pharm J"},{"key":"149_CR27","unstructured":"Reed K, Bond A, Witton J, Cornish R, Hickman M, Strang J. The changing use of prescribed benzodiazepines and z-drugs and of over-the-counter codeine-containing products in England: a structured review of published English and international evidence and available data to inform consideration of the extent of dependence and harm. In: National Addiction Centre KCL, and School of Social and Community Medicine, University of Bristol, editor. London: Kings College London; 2011."},{"issue":"4","key":"149_CR28","first-page":"793","volume":"38","author":"J Wright","year":"2016","unstructured":"Wright J, Bond CM, Robertson HD, Matheson C. Changes in over-the-counter drug misuse over 20 years: perceptions from Scottish pharmacists. J. Public Health. 2016;38(4):793\u20139.","journal-title":"J. Public Health"},{"key":"149_CR29","doi-asserted-by":"crossref","unstructured":"Van Hout MC, Rich E, Dada S, Bergin M. Codeine is my Helper: A qualitative study of pharmacy access and codeine misuse in South Africa. Qual Health Res. 2015; ahead of print","DOI":"10.1177\/1049732315613764"},{"issue":"2","key":"149_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5694\/mja12.10785","volume":"198","author":"F Shand","year":"2013","unstructured":"Shand F, Campbell G, Hall W, Lintzeris N, Cohen M, Degenhardt L. Real-time monitoring of schedule 8 medicines in Australia: evaluation is essential. Med J Aus. 2013;198(2):80\u20131.","journal-title":"Med J Aus"},{"key":"149_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1515\/acph-2015-0040","volume":"65","author":"M Bergin","year":"2015","unstructured":"Bergin M, Norman I, Foley M, Harris R, Rapca A, Rich E, et al. Practice implications and recommendations for managing codeine misuse and dependence. Acta Pharma. 2015;65:351\u201364.","journal-title":"Acta Pharma"},{"key":"149_CR32","volume-title":"A scoping review of codeine use, misuse and dependence, final report","author":"M Van Hout","year":"2014","unstructured":"Van Hout M, Bergin M, Foley M, Rich E, Rapca A, Harris R, et al. A scoping review of codeine use, misuse and dependence, final report. 2014."},{"issue":"5","key":"149_CR33","first-page":"43","volume":"80","author":"K Le Roux","year":"2013","unstructured":"Le Roux K. Marketing of CPS. SAPJ. 2013;80(5):43\u20137.","journal-title":"SAPJ"},{"issue":"1168","key":"149_CR34","first-page":"18","volume":"98","author":"M Haggan","year":"2017","unstructured":"Haggan M. Year in review: Codeine: An unscheduled dilemma. AJP. 2017;98(1168):18.","journal-title":"AJP"},{"issue":"1","key":"149_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.drugpo.2009.02.002","volume":"21","author":"J Sheridan","year":"2010","unstructured":"Sheridan J, Butler R. \u201cThey\u2019re legal so they\u2019re safe, right?\u201d what did the legal status of BZP-party pills mean to young people in New Zealand? Int J Drug Policy. 2010;21(1):77\u201381.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"149_CR36","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1176\/appi.ps.55.12.1434","volume":"55","author":"V Phokeo","year":"2004","unstructured":"Phokeo V, Sproule B, Raman-Wilms L. Community Pharmacists\u2019 attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv. 2004;55(12):1434\u20136.","journal-title":"Psychiatr Serv"},{"key":"149_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2710.2004.00611.x","volume":"30","author":"K Berger","year":"2005","unstructured":"Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther. 2005;30:45\u201357.","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"149_CR38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s11096-007-9086-2","volume":"29","author":"SI Benrimoj","year":"2007","unstructured":"Benrimoj SI, Gilbert A, Quintrell N, Neto AC. Non-prescription medicines: a process for standards development and testing in community pharmacy. Pharm World Sci. 2007;29(4):386\u201394.","journal-title":"Pharm World Sci"},{"issue":"2","key":"149_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11096-008-9266-8","volume":"31","author":"SI Benrimoj","year":"2009","unstructured":"Benrimoj SI, Gilbert AL, de Almeida Neto AC, Kelly F. National implementation of standards of practice for non-prescription medicines in Australia. Pharm World Sci. 2009;31(2):230\u20137.","journal-title":"Pharm World Sci"},{"issue":"9","key":"149_CR40","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.addbeh.2013.03.020","volume":"38","author":"LE Agnich","year":"2013","unstructured":"Agnich LE, Stogner JM, Miller BL, Marcum CD. Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures. Addict Behav. 2013;38(9):2445\u20139.","journal-title":"Addict Behav"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-018-0149-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13011-018-0149-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-018-0149-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T22:06:48Z","timestamp":1571004408000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-018-0149-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1186\/s13011-018-0149-2","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"19 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research project was reviewed by the South African Medical Research Council, Waterford Institute of Technology and Kings College London, and ethics approval was obtained. Proof of ethics approval can be provided upon request.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"12"}}